Northwire Canada EditionMonday, July 13, 2026
Northwire
GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0% GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0%
Earnings

The "New Vice" Economy: 5 Stocks Profiting from the Shift to Clean Fuel

MOOD · Price

Executive Summary

  • The release highlights a broad consumer shift toward functional wellness products, positioning several companies—including Doseology Sciences, Philip Morris International, Canopy Growth, Zevia, and Lifeway Foods—for growth.
  • Material corporate actions are disclosed: Doseology’s acquisition of Feed That Brain for $400k in securities and its new manufacturing agreement; Zevia’s Q3‑2025 financial results showing a 12.3% sales increase; PMI’s expanded ZYN branding partnership with Scuderia Ferrari HP; Canopy Growth’s launch of high‑THC “Claybourne Gassers” vapes; Lifeway Foods’ recognition on Inc.’s Best Challenger Brands list.
  • These updates collectively indicate positive momentum across the wellness and smoke‑free product sectors, suggesting material upside for the highlighted companies.

Key Details

  • Consumer Trend Insight: 46 million consumer mentions of health‑focused products; 41% of wellness spend driven by younger demographics (36% of adult population).
  • Doseology Sciences Inc.
  • Acquired Feed That Brain (Toronto health supplement brand) for $400,000 in securities; added strategic advisor Joseph Mimran with a three‑year advisory agreement valued at $400,000 in restricted share units.
  • Secured a manufacturing agreement through wholly‑owned subsidiary Doseology USA Inc. to commence commercial production of caffeine, nicotine, and functional ingredient pouches.
  • Launched an Investor Communications Initiative in early December 2025 to improve disclosure practices.
  • Philip Morris International (PMI)
  • Expanded partnership with Scuderia Ferrari HP & Ferrari Challenge Trofeo Pirelli for the 2026 season onward; ZYN nicotine‑pouch branding will appear on F1 liveries beginning at the Abu Dhabi Grand Prix 2025 (Dec 7).
  • Smoke‑free products now represent 41% of PMI’s net revenues for the first nine months of 2025, up from 25% a year earlier.
  • Canopy Growth Corporation
  • Introduced “Claybourne Gassers,” an all‑in‑one vape line featuring 92–98% THC liquid diamonds in three flavors; includes digital display, variable voltage, anti‑burn/clog tech, USB‑C rechargeable format.
  • Launched “Frosted Flyers” 8‑pack (0.35 g each) with 33–36% THC across top‑selling strains; available at licensed retail and select online stores.
  • Zevia PBC
  • Q3‑2025 net sales: $40.8 million (+12.3% YoY); volume growth 12.6%; gross profit margin 45.6% (down 3.5 pts YoY due to inventory losses and tariff impacts).
  • Net loss: $2.8 million (including $0.9 million non‑cash equity compensation); Adjusted EBITDA loss: $1.7 million.
  • Cash & equivalents at Sep 30 2025: ~$26.0 million; no debt; unused credit line $20 million.
  • Lifeway Foods
  • Named to Inc.’s 2025 “Best Challenger Brands” list (Best in Business).
  • Recognized by TIME as a Growth Leader and awarded Dairy Foods’ Processor of the Year 2025.

Notable Quotes

  • “Our strategy is clear: to lead innovation in the oral stimulant category with a sharp focus on speed to market and operational excellence.” – Chris Jackson, CEO, Doseology Sciences Inc.
  • “PMI shares with Scuderia Ferrari HP the pursuit to innovate and challenge the status quo for millions of adults that share this passion.” – Stefano Volpetti, President Smoke‑Free Products & Chief Consumer Officer, PMI
  • “Our strong performance in the third quarter… underscores our continued progress across our strategic growth pillars.” – Amy Taylor, CEO, Zevia PBC
  • “Being recognized by Inc. is an incredible validation of our team's commitment to innovation and impact.” – Julie Smolyansky, CEO, Lifeway Foods

All information extracted from the news release; boilerplate disclaimer and advertising language omitted.

Read the original news release →

More from Doseology Sciences Inc.